Second Chance on Orbit: Why Rocket Lab May Rebound from Its Crash

Hook & thesis

Rocket Lab's share price has shed much of the euphoria that sent it toward a $151 peak in late May. At roughly $64 today, the company is trading at a fraction of that high while still pointing to meaningful revenue growth and a plan to reach positive EBITDA within the next year. That combination - high growth, near-term path to profitability, and a mechanical washout in price and momentum - is exactly the setup traders and active investors look for.

My call is tactical and conditional: buy RKLB at $64.00 with a stop at $56.00 and a target of $95.00 over a long-term horizon (180 trading days). The rationale is straightforward: the market has punished valuation faster than fundamentals have degraded. If Rocket Lab executes on backlog conversion, integrates the planned Iridium acquisition, and edges into positive EBITDA as analysts expect, the stock should re-rate from deeply oversold momentum levels. This is a trade, not a blind long-term endorsement.

What Rocket Lab does and why the market should care

Rocket Lab develops rocket launch and spacecraft systems across two operating segments: Launch Services (dedicated and ride-share launches) and Space Systems (spacecraft engineering, components, manufacturing and on-orbit operations). The company is moving beyond pure launch into components and satellite subsystems through targeted acquisitions and internal scaling. One recent description of the business mix places more than 70% of revenue coming from space systems, which changes the narrative from a pure-play launch business to a diversified space infrastructure supplier.

Why this matters to investors now:

• Scale and diversification. The company is expanding into reaction wheels, star trackers, batteries, solar arrays and other components via acquisitions, which increases addressable revenue and builds recurring hardware/service lines.
• Growth runway. Street models referenced in recent coverage point to a roughly 43% revenue CAGR through 2028 and an expected move to positive EBITDA by 2027. That path supports a materially higher valuation if execution is delivered.
• Strategic M&A. Management is pursuing the Iridium acquisition (roughly $8 billion reported), which, if completed and integrated, would materially change Rocket Lab's revenue profile and customer mix toward satellite communications scale.

Hard numbers that matter

Two points jump off the table: the company is unprofitable today and burning cash, but the top-line growth expectations and strategic moves give a plausible path to profitability in the next 12-24 months. The market has already priced in risk — the P/S of ~53x is aggressive and reflects lofty expectations. That multiple implies the business must produce strong revenue and margin expansion; the trade here is betting the company will make material progress and the stock will re-rate from a momentum-driven drawdown.

Technical and sentiment backdrop

Short-term momentum is weak: the 10-day SMA sits near $65.07 and the 50-day SMA at $74.91, while the RSI is about 36.4, indicating room to consolidate or bounce. Short interest has been elevated recently with around 44 million shares on the borrow at mid-August settlement figures and days-to-cover north of two on some readings. Heavy short volume through early September suggests both downside pressure and the potential for squeezes if a positive catalyst materializes.

Catalysts that would drive the trade

• Earnings / guidance beats - A revenue or margin beat and improved 2027 profitability guide would be the clearest fundamental trigger.
• Progress on Iridium transaction - Any regulatory green light updates or constructive integration details would materially reframe growth expectations.
• Execution on spacecraft production - Evidence that acquired component lines are scaling (bookings, manufacturing throughput, margin improvement) would validate the diversification thesis.
• Launch cadence and reliability - A string of successful, on-time launches supporting backlog conversion reduces execution risk and reassures customers.
• Macro/sector rotation - If capital rotates back into high-growth space names after the SpaceX share unlock noise, RKLB could easily catch a bid given liquidity and short interest.

Trade plan (actionable)

Entry: Buy at $64.00.

Stop loss: $56.00.

Target: $95.00.

Horizon: long term (180 trading days) - allow time for quarterly results, early integration milestones on the Iridium deal, and margin progress to show up in statements and guidance.

Why these levels? The entry is at current market levels and respects the recent pullback. The stop at $56.00 limits downside should negative surprises materialize (more on triggers below) and sits below near-term technical support while keeping position sizing reasonable. The $95 target reflects a re-rating toward a more constructive forward multiple if revenue growth accelerates and EBITDA turns positive; it is a ~48% upside from the entry and is achievable within a 6-9 month window if catalysts line up.

Risk framing - what can go wrong

• Valuation remains stretched. At a P/S north of 50x and a market cap around $38.3B, investors are paying for highly optimistic growth and margin improvement. If revenue growth falls short, the multiple can compress rapidly.
• Execution & integration risk. The Iridium deal (reported ~$8B) and multiple small acquisitions require flawless integration. Missteps, cost overruns, or delays would hurt both cash flow and investor confidence.
• Cash burn and funding risk. Rocket Lab posted negative free cash flow of ~$371.1M in the latest period. Continued burn could force dilution, debt raises, or asset sales that impair returns for existing shareholders.
• Launch and technical failures. A failed launch or repeated reliability issues would hit both revenue and the longer-term commercial reputation, staging a fresh sell-off.
• Competition and pricing pressure. Rival launch providers and larger incumbents can pressure pricing, reduce margins on ride-share launches or component sales, and slow new customer wins.
• Macroeconomic and funding environment. A risk-off market or sector rotation away from growth names could keep RKLB depressed irrespective of company-level progress.

Counterargument: The bear case is credible: Rocket Lab trades at a very high multiple while burning cash. If the company misses revenue cadence, fails to integrate Iridium or needs to raise capital, the stock can trade well below current levels—potentially retesting the low-$30s. That scenario validates tight risk controls and the defined stop.

Why this still looks like a second chance

Despite the bear case, a few practical dynamics favor the long here as a trade rather than an investment call. First, elevated short interest and heavy short volume create asymmetric upside if even a modest positive surprise arrives. Second, analysts expect a move to positive EBITDA by 2027 and project high revenue CAGR through 2028; those are binary-ish milestones that can re-rate the stock. Third, Rocket Lab's shift into higher-margin spacecraft components and systems diversifies revenue away from the commodity-like risk of launches and into recurring hardware and services.

What would change my mind

• Missed guidance on the next quarterly report, especially if management lowers revenue or profitability forecasts materially.
• Evidence that the Iridium deal is likely to be derailed, blocked or so dilutive it forces a major restructuring of the transaction terms.
• Two or more launch failures or systemic manufacturing problems across newly acquired component lines.

Conclusion

This is a tactical, high-conviction trade that accepts near-term volatility and execution risk for the potential of a material re-rating. The combination of elevated short interest, stretched technical indicators and a high bar priced into fundamentals makes $64.00 an attractive entry point for a disciplined long with a defined stop and a 180 trading-day window. Keep position sizes controlled and re-evaluate after the next earnings print and any Iridium transaction update; those two events will tell the story and determine whether this rebound is sustainable.

Key actionables

• Enter at $64.00; stop at $56.00; target $95.00.
• Reassess after the next quarterly results and any regulatory / integration milestones on the Iridium deal.
• Keep position sizing modest — this is a high-risk, event-driven trade.